{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:26:45Z","timestamp":1791433605989,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","award":["1002"],"award-info":[{"award-number":["1002"]}],"id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Crohn\u2019s disease (CD) is characterised by recurrent gastrointestinal inflammation. Epigenetic modifications, particularly the methylation of histone H3 at lysine 27 trimethylation (H3K27me3), are crucial in regulating gene expression and macrophage activity. Dysregulation of these modifications may contribute to CD pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the role of H3K27me3 in CD, assess the involvement of the WNK1-TAK1 signalling pathway, and evaluate the therapeutic potential of GSK-J4, a selective histone demethylase inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Peripheral blood and intestinal tissue were collected from CD patients (\n                      <jats:italic>n<\/jats:italic>\n                      = 19) undergoing surgical resection and from age-matched healthy controls (HC,\n                      <jats:italic>n<\/jats:italic>\n                      = 17). Monocytes were isolated and differentiated into macrophages. Expression of H3K27me3, demethylases KDM6A and KDM6B, and components of the WNK1-TAK1 pathway were assessed by Immunofluorescence, Western blotting, and qRT-PCR. GSK-J4 was used to assess its effect on these markers and cytokine secretion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inflamed CD tissue and derived macrophages showed increased KDM6A\/B expression and reduced H3K27me3 compared with unaffected tissue and HC-derived macrophages. GSK-J4 treatment reversed this epigenetic profile and significantly reduced secretion of inflammatory cytokines IL-6, IL-10, and TNF-\u03b1. Activation of the WNK1-TAK1 axis was identified as a key mediator of lipopolysaccharide-induced cytokine release and was modulated by GSK-J4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies KDM6A\/B-driven epigenetic dysregulation as a novel pathogenetic mechanism in CD. GSK-J4 effectively restores H3K27me3 levels and reduces inflammation, supporting histone demethylase inhibition as a promising and mechanistically novel therapeutic approach warranting further translational investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02165-2","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:04:22Z","timestamp":1779379462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Histone H3K27 demethylation drives Crohn\u2019s disease inflammation: GSK-J4 as a potential epigenetic therapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Jigisha A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Beatson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeries","family":"Abu-Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijan","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Loizidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie H.","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Richard Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahmoud Rajab","family":"Eddama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"1","key":"2165_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn\u2019s disease. Nat Rev Dis Prim. 2020;6(1):22.","journal-title":"Nat Reviews Disease Primers"},{"issue":"10","key":"2165_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/apt.15701","volume":"51","author":"D King","year":"2020","unstructured":"King D, Reulen RC, Thomas T, Chandan JS, Thayakaran R, Subramanian A, et al. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000\u20132018. Aliment Pharmacol Ther. 2020;51(10):922\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2165_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46\u2013e54. 42; quiz e30.","journal-title":"Gastroenterology"},{"issue":"5","key":"2165_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cgh.2022.02.044","volume":"21","author":"M Kayal","year":"2023","unstructured":"Kayal M, Ungaro RC, Bader G, Colombel JF, Sandborn WJ, Stalgis C. Net remission rates with biologic treatment in Crohn\u2019s disease: a reappraisal of the clinical trial data. Clin Gastroenterol Hepatol. 2023;21(5):1348\u201350.","journal-title":"Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association"},{"issue":"5","key":"2165_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2468-1253(19)30012-3","volume":"4","author":"NA Kennedy","year":"2019","unstructured":"Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, et al. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2019;4(5):341\u201353.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"2165_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S2468-1253(24)00044-X","volume":"9","author":"N Chanchlani","year":"2024","unstructured":"Chanchlani N, Lin S, Bewshea C, Hamilton B, Thomas A, Smith R, et al. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn\u2019s disease: 3-year data from the prospective, multicentre PANTS cohort study. Lancet Gastroenterol Hepatol. 2024;9(6):521\u201338.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2165_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/apt.16615","volume":"55","author":"J Burisch","year":"2022","unstructured":"Burisch J, Lophaven S, Langholz E, Munkholm P. The clinical course of Crohn\u2019s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962\u20132017. Aliment Pharmacol Ther. 2022;55(1):73\u201382.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7330","key":"2165_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343\u20139.","journal-title":"Nature"},{"issue":"9","key":"2165_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.cellsig.2014.03.025","volume":"26","author":"Q Yan","year":"2014","unstructured":"Yan Q, Sun L, Zhu Z, Wang L, Li S, Ye RD. Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages. Cell Signal. 2014;26(9):1783\u201391.","journal-title":"Cell Signal"},{"issue":"6","key":"2165_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","volume":"130","author":"F De Santa","year":"2007","unstructured":"De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell. 2007;130(6):1083\u201394.","journal-title":"Cell"},{"issue":"21","key":"2165_CR11","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1038\/emboj.2009.271","volume":"28","author":"F De Santa","year":"2009","unstructured":"De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 2009;28(21):3341\u201352.","journal-title":"EMBO J"},{"issue":"7411","key":"2165_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature11262","volume":"488","author":"L Kruidenier","year":"2012","unstructured":"Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488(7411):404\u20138.","journal-title":"Nature"},{"issue":"10432","key":"2165_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403(10432):1177\u201391.","journal-title":"Lancet"},{"issue":"9511","key":"2165_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0140-6736(06)68265-2","volume":"367","author":"DJ Marks","year":"2006","unstructured":"Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, et al. Defective acute inflammation in Crohn\u2019s disease: a clinical investigation. Lancet. 2006;367(9511):668\u201378.","journal-title":"Lancet"},{"issue":"1","key":"2165_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn\u2019s disease. Nat Rev Dis Prim. 2020;6(1):22.","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"2165_CR16","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1007\/s00018-012-1246-4","volume":"70","author":"M Salem","year":"2013","unstructured":"Salem M, Seidelin JB, Rogler G, Nielsen OH. Muramyl dipeptide responsive pathways in Crohn\u2019s disease: from NOD2 and beyond. Cell Mol Life Sci. 2013;70(18):3391\u2013404.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"2165_CR17","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.bbrc.2020.10.007","volume":"533","author":"Y Arai","year":"2020","unstructured":"Arai Y, Asano K, Mandai S, Ando F, Susa K, Mori T, et al. WNK1-TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages. Biochem Biophys Res Commun. 2020;533(4):1290\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2165_CR18","doi-asserted-by":"crossref","unstructured":"Liu Z, Kong F, Vallance JE, Harmel-Laws E, Amarachintha S, Steinbrecher KA, et al. Activation of TGF-\u03b2 activated kinase 1 promotes colon mucosal pathogenesis in inflammatory bowel disease. Physiol Rep. 2017;5(7):e13181.","DOI":"10.14814\/phy2.13181"},{"key":"2165_CR19","doi-asserted-by":"publisher","first-page":"109000","DOI":"10.1016\/j.intimp.2022.109000","volume":"110","author":"XY Leng","year":"2022","unstructured":"Leng XY, Yang J, Fan H, Chen QY, Cheng BJ, He HX, et al. JMJD3\/H3K27me3 epigenetic modification regulates Th17\/Treg cell differentiation in ulcerative colitis. Int Immunopharmacol. 2022;110:109000.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2165_CR20","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1096\/fj.201902200RR","volume":"34","author":"M Huang","year":"2020","unstructured":"Huang M, Wang Q, Long F, Di Y, Wang J, Zhun Zhu Y, et al. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice. Faseb j. 2020;34(3):4107\u201319.","journal-title":"Faseb j"},{"key":"2165_CR21","doi-asserted-by":"publisher","first-page":"115165","DOI":"10.1016\/j.bcp.2022.115165","volume":"203","author":"S Ma","year":"2022","unstructured":"Ma S, Xu L, Chen L, Sun X, Hu F, Gong Y, et al. Novel pharmacological inhibition of JMJD3 improves necrotizing enterocolitis by attenuating the inflammatory response and ameliorating intestinal injury. Biochem Pharmacol. 2022;203:115165.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2165_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jcb.24463","volume":"114","author":"N Turgeon","year":"2013","unstructured":"Turgeon N, Blais M, Delabre JF, Asselin C. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response. J Cell Biochem. 2013;114(5):1203\u201315.","journal-title":"J Cell Biochem"},{"issue":"3","key":"2165_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jcmgh.2020.11.009","volume":"11","author":"C Felice","year":"2021","unstructured":"Felice C, Lewis A, Iqbal S, Gordon H, Rigoni A, Colombo MP, et al. Intestinal inflammation is linked to hypoacetylation of histone 3 lysine 27 and can be reversed by valproic acid treatment in inflammatory bowel disease patients. Cell Mol Gastroenterol Hepatol. 2021;11(3):889\u2013e916.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2165_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1572-0241.2005.40615.x","volume":"100","author":"J Mudter","year":"2005","unstructured":"Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol. 2005;100(1):64\u201372.","journal-title":"Am J Gastroenterol"},{"issue":"33","key":"2165_CR25","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.3748\/wjg.14.5110","volume":"14","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K. Role of STAT3 in inflammatory bowel disease. World J Gastroenterol. 2008;14(33):5110\u20134.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2165_CR26","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41598-020-79122-3","volume":"11","author":"C Do\u00f1as","year":"2021","unstructured":"Do\u00f1as C, Neira J, Osorio-Barrios F, Carrasco M, Fern\u00e1ndez D, Prado C, et al. The demethylase inhibitor GSK-J4 limits inflammatory colitis by promoting de novo synthesis of retinoic acid in dendritic cells. Sci Rep. 2021;11(1):1342.","journal-title":"Sci Rep"},{"issue":"12","key":"2165_CR27","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.4049\/jimmunol.1001952","volume":"186","author":"OM Pena","year":"2011","unstructured":"Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol. 2011;186(12):7243\u201354.","journal-title":"J Immunol"},{"issue":"1","key":"2165_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.gastro.2010.09.009","volume":"140","author":"M Hedl","year":"2011","unstructured":"Hedl M, Abraham C. Secretory mediators regulate Nod2-induced tolerance in human macrophages. Gastroenterology. 2011;140(1):231\u201341.","journal-title":"Gastroenterology"},{"issue":"15","key":"2165_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1042\/CS20220531","volume":"137","author":"Z Strizova","year":"2023","unstructured":"Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, et al. M1\/M2 macrophages and their overlaps\u2014myth or reality? Clin Sci (Lond). 2023;137(15):1067\u201393.","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"2165_CR30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/ibd\/izab029","volume":"27","author":"S Dharmasiri","year":"2021","unstructured":"Dharmasiri S, Garrido-Martin EM, Harris RJ, Bateman AC, Collins JE, Cummings JRF, et al. Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflamm Bowel Dis. 2021;27(10):1641\u201352.","journal-title":"Inflamm Bowel Dis"},{"issue":"26","key":"2165_CR31","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3748\/wjg.v28.i26.3063","volume":"28","author":"N Okai","year":"2022","unstructured":"Okai N, Watanabe T, Minaga K, Kamata K, Honjo H, Kudo M. Alterations of autophagic and innate immune responses by the Crohn\u2019s disease-associated. World J Gastroenterol. 2022;28(26):3063\u201370.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2165_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/00365521.2014.966321","volume":"50","author":"JM Davies","year":"2015","unstructured":"Davies JM, Abreu MT. The innate immune system and inflammatory bowel disease. Scand J Gastroenterol. 2015;50(1):24\u201333.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"2165_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","volume":"9","author":"OJ McElvaney","year":"2021","unstructured":"McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021;9(6):643\u201354.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"2165_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1086\/315356","volume":"181","author":"PE Dekkers","year":"2000","unstructured":"Dekkers PE, Juffermans NP, ten Hove T, de Jonge E, van Deventer SJ, van der Poll T. Endotoxin down-regulates monocyte and granulocyte interleukin-6 receptors without influencing gp130 expression in humans. J Infect Dis. 2000;181(3):1055\u201361.","journal-title":"J Infect Dis"},{"issue":"5","key":"2165_CR35","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.170.5.1537","volume":"170","author":"J Bauer","year":"1989","unstructured":"Bauer J, Bauer TM, Kalb T, Taga T, Lengyel G, Hirano T, et al. Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med. 1989;170(5):1537\u201349.","journal-title":"J Exp Med"},{"key":"2165_CR36","doi-asserted-by":"crossref","unstructured":"Zhou M, Aziz M, Denning NL, Yen HT, Ma G, Wang P. Extracellular CIRP induces macrophage endotoxin tolerance through IL-6R-mediated STAT3 activation. JCI Insight. 2020;5(5):e133715.","DOI":"10.1172\/jci.insight.133715"},{"issue":"11","key":"2165_CR37","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.4049\/jimmunol.1002041","volume":"185","author":"SS Iyer","year":"2010","unstructured":"Iyer SS, Ghaffari AA, Cheng G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J Immunol. 2010;185(11):6599\u2013607.","journal-title":"J Immunol"},{"key":"2165_CR38","doi-asserted-by":"publisher","first-page":"3451461","DOI":"10.1155\/2019\/3451461","volume":"2019","author":"O Ernst","year":"2019","unstructured":"Ernst O, Glucksam-Galnoy Y, Athamna M, Ben-Dror I, Ben-Arosh H, Levy-Rimler G, et al. The cAMP pathway amplifies early MyD88-dependent and type I interferon-independent LPS-induced interleukin-10 expression in mouse macrophages. Mediators Inflamm. 2019;2019:3451461.","journal-title":"Mediators Inflamm"},{"key":"2165_CR39","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3389\/fimmu.2019.01788","volume":"10","author":"O Ernst","year":"2019","unstructured":"Ernst O, Glucksam-Galnoy Y, Bhatta B, Athamna M, Ben-Dror I, Glick Y, et al. Exclusive temporal stimulation of IL-10 expression in LPS-stimulated mouse macrophages by cAMP inducers and type I interferons. Front Immunol. 2019;10:1788.","journal-title":"Front Immunol"},{"issue":"1","key":"2165_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jcb.27547","volume":"120","author":"D Liu","year":"2019","unstructured":"Liu D, Cao S, Zhou Y, Xiong Y. Recent advances in endotoxin tolerance. J Cell Biochem. 2019;120(1):56\u201370.","journal-title":"J Cell Biochem"},{"issue":"5","key":"2165_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1084\/jem.181.5.1887","volume":"181","author":"F Randow","year":"1995","unstructured":"Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med. 1995;181(5):1887\u201392.","journal-title":"J Exp Med"},{"issue":"11","key":"2165_CR42","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","volume":"8","author":"MH Barros","year":"2013","unstructured":"Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE. 2013;8(11):e80908.","journal-title":"PLoS ONE"},{"issue":"10","key":"2165_CR43","doi-asserted-by":"publisher","first-page":"e78045","DOI":"10.1371\/journal.pone.0078045","volume":"8","author":"NA Kittan","year":"2013","unstructured":"Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, et al. Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS ONE. 2013;8(10):e78045.","journal-title":"PLoS ONE"},{"issue":"1","key":"2165_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cellimm.2013.01.010","volume":"281","author":"M Jaguin","year":"2013","unstructured":"Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol. 2013;281(1):51\u201361.","journal-title":"Cell Immunol"},{"issue":"1","key":"2165_CR45","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1038\/s41598-022-11503-2","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li S, Liu F, Yang K. Role of CD68 in tumor immunity and prognosis prediction in pan-cancer. Sci Rep. 2022;12(1):7844.","journal-title":"Sci Rep"},{"key":"2165_CR46","doi-asserted-by":"publisher","first-page":"1599677","DOI":"10.3389\/fimmu.2025.1599677","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang H, Dai R, Zheng D, Zhao J, Jing H, et al. CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints. Front Immunol. 2025;16:1599677.","journal-title":"Front Immunol"},{"issue":"6","key":"2165_CR47","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.21873\/invivo.11415","volume":"32","author":"H Lee","year":"2018","unstructured":"Lee H, Lee HJ, Song IH, Bang WS, Heo SH, Gong G, et al. CD11c-positive dendritic cells in triple-negative breast cancer. In Vivo. 2018;32(6):1561\u20139.","journal-title":"Vivo"},{"issue":"3","key":"2165_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/JLB.6A1120-744R","volume":"111","author":"CB Anders","year":"2022","unstructured":"Anders CB, Lawton TMW, Smith HL, Garret J, Doucette MM, Ammons MCB. Use of integrated metabolomics, transcriptomics, and signal protein profile to characterize the effector function and associated metabotype of polarized macrophage phenotypes. J Leukoc Biol. 2022;111(3):667\u201393.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"2165_CR49","doi-asserted-by":"publisher","first-page":"e69839","DOI":"10.1371\/journal.pone.0069839","volume":"8","author":"E Franz\u00e8","year":"2013","unstructured":"Franz\u00e8 E, Caruso R, Stolfi C, Sarra M, Cupi ML, Caprioli F, et al. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease. PLoS ONE. 2013;8(7):e69839.","journal-title":"PLoS ONE"},{"issue":"1","key":"2165_CR50","doi-asserted-by":"publisher","first-page":"19616","DOI":"10.1038\/s41598-021-98611-7","volume":"11","author":"PB Wright","year":"2021","unstructured":"Wright PB, McDonald E, Bravo-Blas A, Baer HM, Heawood A, Bain CC, et al. The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease. Sci Rep. 2021;11(1):19616.","journal-title":"Sci Rep"},{"key":"2165_CR51","doi-asserted-by":"publisher","first-page":"7479540","DOI":"10.1155\/2021\/7479540","volume":"2021","author":"Z Baydi","year":"2021","unstructured":"Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, et al. An update of research animal models of inflammatory bowel disease. Sci World J. 2021;2021:7479540.","journal-title":"ScientificWorldJournal"},{"key":"2165_CR52","doi-asserted-by":"crossref","unstructured":"Bonovas S, Fiorino G, Allocca M, Lytras T, Nikolopoulos GK, Peyrin-Biroulet L, et al. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2016;14(10):1385-97","DOI":"10.1016\/j.cgh.2016.04.039"},{"issue":"7","key":"2165_CR53","first-page":"1365","volume":"22","author":"JE Axelrad","year":"2024","unstructured":"Axelrad JE, Hashash JG, Itzkowitz SH. AGA clinical practice update on management of inflammatory bowel disease in patients with malignancy: commentary. J Am Gastroenterol Assoc. 2024;22(7):1365\u201372.","journal-title":"J Am Gastroenterological Association"},{"key":"2165_CR54","unstructured":"Santiago P, Braga-Neto MB, Loftus EV. Novel therapies for patients with inflammatory bowel disease. Gastroenterol Hepatol. 2022;18(8):453\u201365."},{"key":"2165_CR55","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3389\/fimmu.2018.02272","volume":"9","author":"Y Pan","year":"2018","unstructured":"Pan Y, Wang J, Xue Y, Zhao J, Li D, Zhang S, et al. GSKJ4 protects mice against early sepsis via reducing proinflammatory factors and up-regulating MiR-146a. Front Immunol. 2018;9:2272.","journal-title":"Front Immunol"},{"issue":"22","key":"2165_CR56","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.7150\/thno.47081","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Ying Y, Li M, Wang M, Huang X, Jia M, et al. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer. Theranostics. 2020;10(22):10016\u201330.","journal-title":"Theranostics"},{"issue":"40","key":"2165_CR57","doi-asserted-by":"publisher","first-page":"68591","DOI":"10.18632\/oncotarget.19793","volume":"8","author":"A Sui","year":"2017","unstructured":"Sui A, Xu Y, Li Y, Hu Q, Wang Z, Zhang H, et al. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells. Oncotarget. 2017;8(40):68591\u20138.","journal-title":"Oncotarget"},{"issue":"1","key":"2165_CR58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13148-022-01305-8","volume":"14","author":"J Abu-Hanna","year":"2022","unstructured":"Abu-Hanna J, Patel JA, Anastasakis E, Cohen R, Clapp LH, Loizidou M, et al. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Clin Epigenetics. 2022;14(1):98.","journal-title":"Clin Epigenetics"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02165-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:25:32Z","timestamp":1784089532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02165-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02165-2","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki. Ethical approval was obtained from the Health Research Authority and Health and Care Research Wales (Research Ethics Committee [REC] reference: 21\/NW\/0023) and the University College London\u2013Royal Free Hospital (UCL-RFH) Research Ethics Committee. All participants provided written informed consent to participate in this study in accordance with the Declaration of Helsinki and institutional ethical guidelines.","order":1,"name":"Ethics","label":"Ethica approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no personal financial interests or relationships that could be perceived to influence the work reported in this manuscript. The corresponding author (M.M.R.E.) has previously participated in fundraising activities for Crohn\u2019s and Colitis in Childhood, the charity that provided funding support for this project. The late Michael Seres, who served as the Patient and Public Involvement (PPI) lead, also contributed to fundraising activities. The authors do not believe these activities have influenced the design, conduct, or reporting of the study.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"144"}}